
Join to view full profile
Beth Israel Medical Center330 Brookline AveBoston, MA 02215
Phone+1 617-667-5561
Dr. Tenen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1982 - 1984
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1978 - 1981
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1977
Harvard Medical SchoolClass of 1975
Certifications & Licensure
CA State Medical License 1977 - Present
MA State Medical License 1976 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- RNAs anchoring replication complex control initiation and firing of DNA replication.Simone Ummarino, Larysa Poluben, Alexander K Ebralidze, Ida Autiero, Lucrezia Rinaldi
Nature Communications. 2026-05-27 - Targeted protein degradation for fetal hemoglobin induction: a new paradigm in β-hemoglobinopathy therapy.Sanjana Arji, Ziyang Shen, Sabrina Welch, Fadila ElMahdaoui, Ayana Bahadur
Biomarker Research. 2026-04-28 - 1 citationsThe C/EBPα-(PU.1-LOUP) regulatory circuit regulates monocyte/macrophage development and immune functions.A S M Waliullah, Thuy-An Nguyen, Barbara Dziegielewska, Junyan Zhang, Kevin Qiu
Blood. 2026-04-23
Press Mentions
Mutant p53 Drives Clonal Hematopoiesis Through Modulating Epigenetic PathwayDecember 11th, 2019
Grant Support
- Molecular Biology Of Myeloid DifferentiationNational Heart, Lung, And Blood Institute2012
- Oncogenesis And Myeloid Transcription Factors In AMLNational Cancer Institute2008–2012
- Hematopoietic Stem Cell CommitmentNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Targeting Leukemic Stem CellsNational Cancer Institute2008–2011
- Distinct Acute Myeloid Leukemia Subclasses With Cebpa MutationsNational Cancer Institute2007–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









